Improving cancer outcomes and leadership course: a European initiative
27.03.2025 - 11.05.2025
HYBRID EVENT
COURSES AND SEMINARS
Description
Chairs: A. Eniu, CH/RO - R. Popescu, CH - P. Selby, UK - T. Spanic, SI
INTRODUCTION
The Improving Cancer Outcomes and Leadership course aims to address the challenging issue of inequalities in cancer outcomes across Europe and is designed to equip mid-career cancer healthcare professionals (of all disciplines), industry experts, patient advocates, and regulatory personnel with essential skills for strategic planning, applied health research, implementation strategies, and change management to enhance care quality and patient outcomes in their regions.
The Training Programme will be developed in close collaboration with patients and patient advocates to ensure that we retain a patient-centred approach. The Training Programme will address overarching issues including early diagnosis, specialised multidisciplinary care, patient-centred approaches, integrated care and the systematic use of existing knowledge. It will engender within participants a clear recognition of the importance of Research and Innovation and clinical trials to 21st century patient care
It is intended that the participants of this course will represent many European countries and that they will remain in contact and develop a network for shared approaches and best practice.
Participants will be asked to share examples showing initiatives and challenges to improve clinical practice in their countries during the course.
Learning Objectives:
- Build the skills and train individuals to work to improve cancer patient outcomes
- Share examples of best practice across Europe
- Create a network of trained individuals who will continue to work together to improve cancer patient outcomes
- Allow trainees to work together with senior colleagues and European advisors to develop country-specific proposals for improving outcomes
Main Topics:
- The European Code of Cancer Practice
- Strategic healthcare improvement skills
- Awareness and implementation of good practice
- Innovation based on sound evidence and the appropriate interpretation of RCT data
- Change management skills
To learn more about the course structure and the potential benefits of participation, take a look at this article recently published in the Journal of Cancer Policy.
Information
The Improving Cancer Outcomes and Leadership course will be a combination of the following:
- Block 1 - Pre-event online learning sessions
- Block 2 - A 3 day in-person event
Location: Zagreb, Croatia
Dates: 8 – 11 May 2025
The online learning sessions must be completed by participants before the in-person event.
FEE
If selected, a registration fee of 150 EUR will be requested in order to confirm your participation in this event.
The registration fee covers:
- Access to the course and its educational resources
- Accommodation for 3 nights at the event venue
- Meals according to the programme
The fee does not cover travel costs, these should be organized and paid by the participant.
Participants who are ESO College members at the time of application will receive a 50% discount.
ESO College Graduates are exempt from paying the registration fee as part of their ESCO Benefits.
The registration fee for this event is a small contribution towards the cost for organising it, therefore it will not be refunded if a participant withdraws or is unable to attend, for whatever reason.
ACCREDITATION
Participants will be issued a certificate of attendance (minimum attendance: 75% of the entire course). An online evaluation questionnaire and learning assessment test will need to be completed in order to get the certificate that will be issued by email.
The Accreditation Council of Oncology in Europe (ACOE) has awarded this course 18.5 CME credits. The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.
ESO COLLEGE MEMBERSHIP
Being selected to take part in this course is one of the ESO activities that gives participants eligibility to enrol in ESO’s College. The course also enables members of the College to earn credits and therefore access more membership benefits. Full and active participation in the course earns participants 18 ESO College credits.
Visit www.ESCO.org for more information on how to join the College.
ORGANISING SECRETARIAT
Corinne Hall
European School of Oncology
ph + 39 331 6125784
Email: chall@eso.net
Dolores Knupfer
European School of Oncology
ph +41 91 820 09 50
e-mail: dknupfer@eso.net
Language
The course will be held in English and translation will not be provided.
Insurance
The organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.
Programme
Application
ATTENDANCE TO THE COURSE IS BY APPLICATION ONLY
APPLICATIONS DEADLINE - 7 February 2025
Participant’s profile
- Mid-career oncology professionals who have finished training and have a stable position. Involved in or starting to be involved in improving outcomes. Preparing to take on initiatives/leadership responsibilities/managerial roles;
- Mid-career managers of hospitals or clinics;
- Mid-career Health Care Professionals with managerial roles;
- Mid-high-level representatives of patient organisations;
- Industry representatives;
- Regulatory bodies.
Priority and free registration is given to Graduates enrolled in ESO’s College.
Fluency in English is required
How to apply
Interested candidates should apply online providing the following:
- CV & list of publications if oncology professional or affiliation if patient advocate/industry/regulatory body;
- Motivation letter;
- Completed template for Examples of initiatives and challenges.
Examples of initiatives and challenges template
Please complete the attached template giving an example of practice that has changed outcomes, or a practice that was implemented to change outcomes but didn’t work. Selected participants will have the opportunity to present their example in the format of a slide presentation (max. 10) to the participants and faculty members during the breakout sessions (as mentioned in the programme). Please don’t submit presentations at this stage in the application process.
Faculty
Ajay Aggarwal, London School of Hygiene and Tropical Medicine, Department of Health Services Research and Policy, London, UK
Tit Albreht, National Institute of Public Health, ., Ljubljana, SI
Alberto Costa, European School of Oncology, Director's Office, Milano, IT
Timothy Eisen, University of Cambridge, Dept. of Oncology, Cambridge, UK
Alexandru Eniu, Riviera-Chablais Hospital, Medical Oncology Dpt., Rennaz, CH/RO
Antonio Tito Fojo, Columbia University, Dept. of Medicine / Division of Medical Oncology, New York, NY, US
Matt Hickey, The Health Value Alliance, Management Dept., Epsom, UK
Lynda Holt, Health Service 360, CEO, Stratford upon Avon, UK
Stein Kaasa, Oslo University Hospital, Department of Oncology, Oslo, NO
Assia Konsoulova, National Cancer Hospital, Medical Oncology Clinic, Sofia, BG
Denis Lacombe, EORTC Data Center, NDDP, Brussels, BE
Caroline Lark, Talent for Growth Ltd, ., Tavistock, Devon, UK
Mark Lawler, Queens University Hospital, Centre for Cancer Research and Cell Biology, Belfast, UK
David Nelson, University of Lincoln, Health Dpt., Lincoln, UK
Kathy Oliver, International Brain Tumour Alliance - IBTA, Patient Advocacy Dept., Tadworth, Surrey, UK
Andrea Pace, IRCCS Regina Elena Cancer Institute, Neurooncology Unit, Rome, IT
Steve Pavletic, Bethesda, Maryland, US
Eduardo Pisani, All.Can International, CEO, Brussels, BE
Stjepko Pleština, University Hospital Centre Zagreb, Oncology Department, Zagreb, HR
Razvan Popescu, Tumor Center Aarau / Hirslanden Klinik Aarau, Medical Oncology / Hematology / Palliative Care Dpt., Aarau, CH
Miroslav Samarzija, Clinical Hospital Center Zagreb, Department of Pulmonary Diseases, Zagreb, HR
Peter Selby, Lincoln, UK
Tanja Spanic, Europa Donna Slovenia, Patient Advocacy Dpt., Ljubljana, SI
Richard Sullivan, King's Comprehensive Cancer Centre, Institute of Cancer Policy, London, UK
Ian Tannock, Toronto, CA
Maheva Vallet, University of Edinburgh, Edinburgh Cancer Informatics, Edinburgh, UK
Nils Wilking, Karolinska Institutet, Oncology-Pathology Dept, Stockholm, SE